EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa

P Aarts iD, J C van Huijstee, H H van der Zee, K R van Straalen iD, E P Prens

Journal of the European Academy of Dermatology and Venereology · 2024-05 · 38 (5) · 904-909

DOI: 10.1111/jdv.19725 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 19.12.2023. Verfasst von P Aarts und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Adalimumab, Rifampin, Clindamycin. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adalimumab monotherapy for hidradenitis suppurativa (HS) is often insufficient with a maximum clinical efficacy of 60% in Hidradenitis Suppurativa Clinical Response (HiSCR) and limited effect on draining tunnels. Data suggest that adalimumab therapy could be improved by concomitant antibiotics.

Objective

To compare the clinical effectiveness of adalimumab with clindamycin and rifampicin versus adalimumab monotherapy after 12 weeks.

Methods

This retrospective study included patients who started adalimumab with additional clindamycin and rifampicin and patients treated with adalimumab monotherapy, matched on sex and refined Hurley score. The primary outcome measure was the difference in change in the International Hidradenitis Suppurativa Severity Score System (IHS4) at 12 weeks.

Results

In total, 62 patients were included in the combination therapy group ( n = 31) and adalimumab monotherapy group ( n = 31), showing comparable IHS4 scores; 32.5 versus 29, p = 0.87 at baseline respectively. The combination therapy demonstrated greater clinical effectiveness expressed in median IHS4 improvement (−20 vs. −9, p < 0.001), IHS4‐55 (74% vs. 36%, p = 0.002), median draining tunnel reduction (−4 vs. −2, p < 0.001) and pain response (47% vs. 27%, p = 0.02).

Conclusion

Adalimumab initiated with clindamycin and rifampicin shows greater clinical effectiveness than adalimumab monotherapy. An important difference in effect was observed in the decrease of draining tunnels, addressing a serious limitation of adalimumab monotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdalimumabRifampinClindamycinDrug Therapy, CombinationHumansRetrospective StudiesFemaleMaleAdultMiddle AgedSeverity of Illness IndexAnti-Bacterial AgentsTreatment Outcome

Substanzen

AdalimumabRifampinClindamycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: P Aarts, K R van Straalen

Zitieren

APA

Aarts, P., van Huijstee, J. C., van der Zee, H. H., van Straalen, K. R., & Prens, E. P. (2024). Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology, 38(5), 904-909. https://doi.org/10.1111/jdv.19725

Vancouver

Aarts P, van Huijstee JC, van der Zee HH, van Straalen KR, Prens EP. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology. 2024;38(5):904-909. doi:10.1111/jdv.19725

BibTeX
@article{Aarts2024,
  author = {Aarts, P and van Huijstee, J C and van der Zee, H H and van Straalen, K R and Prens, E P},
  title = {Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  volume = {38},
  number = {5},
  pages = {904--909},
  doi = {10.1111/jdv.19725}
}
Kostenlos starten →